Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
72 Cards in this Set
- Front
- Back
Prototype Drugs
|
Individual drugs that represent groups of drugs; often the first drug of a particular group of which similar drugs are compared
|
|
Polypharmacy
|
the simultaneous use of multiple medications, which increases the risk of drug interaction
|
|
Pharmacokinetics
|
a drugs actions as it moves through the body including how it is absorbed, distributed, metabolized, and excreted. a drugs onset of action, peak concentration level, and duration of action are also included.
|
|
Compliance/adherence
|
fulfilling or following through with a prescribed course of treatment or therapeutic plan
|
|
Medication Error
|
a preventable adverse drug event involving the inappropriate medication use by a patient or provider
|
|
non-compliance/non-adherence
|
an informed decision by the patient to not adhere/follow through with plan/treatment
|
|
additive effects
|
drug interactions that when 2 are combined with similar effects the combined effect is the same as if the drugs were given alone 1+1=2
|
|
adverse drug event
|
any undesirable effect from administering or failing to administer a prescribed medication.
|
|
Adverse drug reaction
|
an unexpected, unintended, undesired, or excessive response to a medication when given at the normal therapeutic dose
|
|
Adverse effects
|
a general term for any undesirable effect in direct response to one or more drugs
|
|
agonist/stimulator
|
a drug which stimulates a receptor (may stimulate the receptor causing an increase in activity or decrease depending on the receptor)
|
|
Antagonist/inhibitors
|
a drug which prevents or inhibits a receptor (prevents a response)
|
|
Competitive Antagonist
|
competes with an agonist for a receptor cite, and can be overcome by increased amounts of an agonist
|
|
Non-competitive antagonist
|
Binds to a receptor and blocks the effect of the agonist. This is a no-contest, it will always win!
|
|
allergic reaction
|
a immunologic hypersensitivity reaction; results from the unusual sensitivity of a patient to a particular drug (type of adverse drug event)
|
|
Antagonistic effects
|
drug interactions which the effects of a combination of one or more drugs are less than the individual effects of the drug 1+1=<2
|
|
bio-availability
|
extent of drug absorption for a given drug and route of administration
|
|
bio-transformation/metabolism
|
the process by which the body changes a drug to a more water-soluble from that can be excreted. Occurs mainly in the liver, and can inactivate the drug
|
|
blood brain barrier
|
a mechanism that doesn't allow many drugs, ions and other compounds to penetrate the brain, it is like a selective filter
|
|
chemical name
|
the name that describes the chemical composition and molecular structure of a drug.
|
|
contraindication
|
any condition which renders a particular form of treatment improper or undesirable.
|
|
cytochrome P-450
|
general name for a large class of enzymes which play a major role in drug metabolism/bio-transformation
|
|
dependence
|
a compulsive or chronic need for a drug
|
|
dissolution
|
the process of disintegrating a solid form of drugs in the GI tract and become soluble before being absorbed for circulation
|
|
drug
|
a chemical that affects the physiologic processes of a living organism
|
|
drug actions/mechanism of action
|
cellular processes involved in the interaction between a drug and body cells (like the drugs actions on receptors)
|
|
drug effects
|
the physiologic reactions of the body to the drug
|
|
drug-induced teratogenesis
|
toxic effects of drugs causing congenital anomalies or defects in a developing fetus.
|
|
drug interaction
|
an alteration of the pharmacologic activity of a drug because of the presences of another drug/or drugs is usually caused by the drug effects on the enzymes needed to metabolize the drugs involved
|
|
duration of action
|
the length of time a drug produces its therapeutic effect
|
|
enzymes
|
protein molecules that catalyze biochemical reactions, including the body's physiologic processes and drug metabolism
|
|
first pass effect
|
the liver may metabolize much of a drug before it enters circulation
|
|
generic name
|
a shorter and simpler version of the chemical name, abbreviation of the chemical name, the non-proprietary name
|
|
half-life
|
the time it takes for half of the drug to be eliminated by the body; is affected by rate of absorption, metabolism, and excretion. Helps to determine dosage frequency
|
|
idiosyncratic reaction
|
an abnormal/unexpected reaction to a medication (not an allergic reaction), and it is peculiar to an individual
|
|
incompatibility
|
a characteristic which causes two drugs or solutions to undergo a reaction when mixed that causes one drug to deteriorate
|
|
intraarticular
|
within a joint
|
|
inrathecal
|
within a sheath
|
|
medication error
|
any preventable adverse drug event involving inappropriate use of a medication by a provider (may or may not cause harm)
|
|
medication use process
|
the prescribing, dispensing, and administering of medications, and the monitoring of their effects
|
|
Parent drug
|
the chemical form of a drug before it is metabolized by the body into active or inactive metabolites
|
|
Metabolite
|
include inactive and active, inactive are changed into execrable substances, active are able to exert their own pharmacologic action, and must undergo further metabolism/or can be excreted in that form
|
|
onset of action
|
the time interval from when a drug is administered until it exerts its therapeutic effect
|
|
peak concentration
|
when the absorption rate equals the elimination rate
|
|
Peak effect
|
time needed for a drug to reach its maximum therapeutic effect (time it take for the drug to work as expected)
|
|
pharmaceutics
|
the science of preparing and dispensing drugs
|
|
pharmacodynamics
|
the study of the drug mechanisms that produce biochemical or physiologic changes in the body`
|
|
pharmacogenetics
|
study of the influence of genetic factors on drug response
|
|
Pharmacognosy
|
study of drugs that are obtained from natural sources (plant and animal)
|
|
pharmacology
|
broad term for the study or science of drugs
|
|
Pharmacotherapeutics
|
treatment of pathologic conditions through the use of drugs
|
|
Prodrug
|
a drug that is not active when administered but is converted to an active form through metabolism (active metabolite)
|
|
Receptor
|
a molecular structure of a cell which bind specific substances
|
|
Steady state
|
the state in which the amount of drug removed through elimination is equal to the amount absorbed with each dose
|
|
substrates
|
substances on which an enzyme acts
|
|
synergistic effects
|
drug interactions where the combination of drugs is equal to more than each separate part 1+1=>2
|
|
Therapeutic drug monitoring
|
measuring a drug peak and trough levels to gauge the level of drug exposure and to adjust dosages, maximize therapeutic effects but minimize toxicity
|
|
tolerance
|
reduced response to a drug after long exposure
|
|
therapeutic effect
|
desired or intended effect of a drug
|
|
therapeutic index
|
ration between toxic and therapeutic doses of a drug
|
|
toxic
|
quality of being poisonous
|
|
toxicity
|
condition of producing adverse bodily effects due to poisonous properties
|
|
toxicology
|
study of poisons, and treatments
|
|
trade name
|
commercial name, proprietary name
|
|
trough level
|
lowest concentration of drug reached in the body after it falls from its peak level
|
|
active transport
|
requires cellular energy to move drugs from lower areas of concentration to higher. NA and K pump uses this as well as the drug levodopa
|
|
diffusion
|
passive movement of a substance from areas of higher concentration to lower concentrations
|
|
elderly
|
a person 65 years and up
|
|
neonate
|
less than 1 month old, newborn
|
|
nomogram
|
a graphic tool for estimating drug dosages using body measurements
|
|
pinocytosis
|
a form of active transport in which a cell engulfs a drug particle (used to transport fat soluble vitamints like A,D,E, K)
|
|
pediatric
|
12 years or younger (1-12)
|